Harrow Inc (HROW)

$50.09 -0.07 (-0.14%)
Market Cap 1.86B
Revenue (ttm) 199.61M
Net Income (ttm) -17.48M
EPS (ttm) N/A
PE Ratio 111.70
Forward PE 71.58
Profit Margin -8.76%
Debt to Equity Ratio 5.21
Volume 443,500
Avg Vol 610,566
Day's Range N/A - N/A
Shares Out 37.04M
Stochastic %K 92%
Beta 0.07
Analysts Strong Sell
Price Target $71.43

Company Profile

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract sur...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 615 733 4730
Address:
1A Burton Hills Boulevard, Suite 200, Nashville, United States
Finnish_boy
Finnish_boy Dec. 26 at 11:14 PM
$HROW ATH in February!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 11:02 PM
$HROW This MVI data shows that Q4 will be enough ok. I think markets start to price in huge growth that happens next year. Markets dont care much will FY25 be 265m, 270m or 275-280m. Q4 report can cause some quick reaction either way but SP is heading to $100 next year !!!! My bet is now that SP wont drop under $40 ever !!!!
1 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 8:54 PM
$HROW HIMS $34, HROW $50.. i was right this time. i told earlier that hrow this year > hims when there was big gap. 95% of times i am wrong. i think hrow wont drop anymore under $40 levels. i think harrow can run to ATH before Q4 report. if report disappoints, hrow can drop under $50, but not to $40. If report awesome, then path to $80 in H1.
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 8:32 PM
$HROW Byqlovi launch in 3 weeks
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 8:20 PM
$HROW Shorts are covering.
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:49 PM
$HROW Shorts thinking should they cover today or tomorrow. I can tell that markets not open tomorrow so have to cover on Monday then !!!!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:47 PM
$HROW I lower odds for under $40 levels from 25% to 10%.
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:32 PM
$HROW ATH in H1 next year. VEVYE momentum will be massive !! coverage, more reps, new markets !! boom!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:31 PM
$HROW VEVYE rocketing started !!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:21 PM
$HROW Very bullish https://x.com/Michigan_Value/status/2004612869246386630?s=20
0 · Reply
Latest News on HROW
Undercovered Dozen: USA Rare Earth, Santacruz Silver, Western Midstream, Visa And More

Dec 8, 2025, 11:31 AM EST - 18 days ago

Undercovered Dozen: USA Rare Earth, Santacruz Silver, Western Midstream, Visa And More

USAR V WES AGNC AGNCM AGNCN AGNCO

Harrow to Present at Two Investor Conferences in December

Nov 24, 2025, 7:00 AM EST - 4 weeks ago

Harrow to Present at Two Investor Conferences in December

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

Nov 18, 2025, 7:00 AM EST - 5 weeks ago

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

Harrow, Inc. (HROW) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 2:11 PM EST - 6 weeks ago

Harrow, Inc. (HROW) Q3 2025 Earnings Call Transcript

Harrow Announces Third Quarter 2025 Financial Results

Nov 10, 2025, 4:05 PM EST - 6 weeks ago

Harrow Announces Third Quarter 2025 Financial Results

Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential

Nov 5, 2025, 12:31 PM EST - 7 weeks ago

Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential

Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025

Oct 27, 2025, 7:00 AM EDT - 2 months ago

Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025

Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other

Oct 15, 2025, 9:03 PM EDT - 2 months ago

Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other

ImprimisRx Announces Leadership Changes

Oct 6, 2025, 7:00 AM EDT - 2 months ago

ImprimisRx Announces Leadership Changes

Harrow, Inc. (HROW) Analyst/Investor Day Transcript

Sep 27, 2025, 12:27 AM EDT - 3 months ago

Harrow, Inc. (HROW) Analyst/Investor Day Transcript

Harrow to Acquire Melt Pharmaceuticals

Sep 26, 2025, 7:00 AM EDT - 3 months ago

Harrow to Acquire Melt Pharmaceuticals

Harrow Launches Harrow Access for All (HAFA)

Sep 25, 2025, 4:05 PM EDT - 3 months ago

Harrow Launches Harrow Access for All (HAFA)

Harrow Announces Agenda and Speakers for Investor & Analyst Day

Sep 15, 2025, 7:00 AM EDT - 3 months ago

Harrow Announces Agenda and Speakers for Investor & Analyst Day

Harrow: Buy A Blend Of Value And Growth

Sep 12, 2025, 10:57 AM EDT - 3 months ago

Harrow: Buy A Blend Of Value And Growth

Harrow: A Classical GARP Stock

Sep 9, 2025, 1:11 PM EDT - 3 months ago

Harrow: A Classical GARP Stock

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

Sep 8, 2025, 5:57 PM EDT - 3 months ago

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030

Sep 8, 2025, 8:00 AM EDT - 3 months ago

Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030

Harrow's Ambitious Guidance Puts It In The Proving Ground

Aug 14, 2025, 11:09 PM EDT - 4 months ago

Harrow's Ambitious Guidance Puts It In The Proving Ground

Harrow: Exciting Times In Store

Aug 13, 2025, 5:39 PM EDT - 4 months ago

Harrow: Exciting Times In Store

Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 2:47 PM EDT - 4 months ago

Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript

Harrow Announces Second-Quarter 2025 Financial Results

Aug 11, 2025, 4:01 PM EDT - 4 months ago

Harrow Announces Second-Quarter 2025 Financial Results

Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference

Aug 6, 2025, 7:00 AM EDT - 5 months ago

Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference

Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025

Jul 29, 2025, 7:00 AM EDT - 5 months ago

Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025

Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States

Jul 17, 2025, 7:00 AM EDT - 5 months ago

Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States

Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States

Jul 17, 2025, 7:00 AM EDT - 5 months ago

Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States

HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm

Jul 15, 2025, 10:38 AM EDT - 5 months ago

HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm

Harrow's Internal $100 Price Target Is Ambitious, But New Bloomberg Data Backs It Up

Jul 11, 2025, 5:47 PM EDT - 6 months ago

Harrow's Internal $100 Price Target Is Ambitious, But New Bloomberg Data Backs It Up

Harrow: Immense Upside Potential

Jul 9, 2025, 2:52 PM EDT - 6 months ago

Harrow: Immense Upside Potential

Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications

Jun 18, 2025, 7:00 AM EDT - 6 months ago

Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications

I Am Swimming In Dividends With +7% Yields

Jun 13, 2025, 8:30 AM EDT - 7 months ago

I Am Swimming In Dividends With +7% Yields

UMH

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals

Jun 9, 2025, 7:00 AM EDT - 7 months ago

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals

Harrow: Epic Growth & Operating Leverage On Full Display

May 28, 2025, 3:20 PM EDT - 7 months ago

Harrow: Epic Growth & Operating Leverage On Full Display

Harrow to Present at Two Investor Conferences in May

May 14, 2025, 7:00 AM EDT - 8 months ago

Harrow to Present at Two Investor Conferences in May

Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript

May 10, 2025, 6:17 PM EDT - 8 months ago

Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript

Harrow Announces First-Quarter 2025 Financial Results

May 8, 2025, 4:01 PM EDT - 8 months ago

Harrow Announces First-Quarter 2025 Financial Results

Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025

May 5, 2025, 7:00 AM EDT - 8 months ago

Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC.

Apr 24, 2025, 10:00 AM EDT - 8 months ago

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC.

Harrow Expands VEVYE® Access for All Program to ImprimisRx's Klarity-C Patients

Apr 10, 2025, 7:00 AM EDT - 9 months ago

Harrow Expands VEVYE® Access for All Program to ImprimisRx's Klarity-C Patients

Harrow: When Cheaper Doesn't Mean Attractive (Rating Upgrade)

Mar 29, 2025, 4:30 PM EDT - 9 months ago

Harrow: When Cheaper Doesn't Mean Attractive (Rating Upgrade)

Harrow, Inc. (HROW) Q4 2024 Earnings Conference Call

Mar 28, 2025, 2:00 PM EDT - 9 months ago

Harrow, Inc. (HROW) Q4 2024 Earnings Conference Call

Harrow Inc.: Roll The Dice For Strong Upside Prospects As Earnings Ramp

Mar 28, 2025, 1:39 PM EDT - 9 months ago

Harrow Inc.: Roll The Dice For Strong Upside Prospects As Earnings Ramp

Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results

Mar 27, 2025, 4:01 PM EDT - 9 months ago

Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results

Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025

Mar 27, 2025, 10:45 AM EDT - 9 months ago

Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025

Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL

Mar 24, 2025, 7:00 AM EDT - 9 months ago

Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL

Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance

Mar 17, 2025, 4:01 PM EDT - 10 months ago

Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance

Harrow Launches VEVYE® Access for All

Mar 17, 2025, 7:00 AM EDT - 10 months ago

Harrow Launches VEVYE® Access for All

Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®

Mar 11, 2025, 7:00 AM EDT - 10 months ago

Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®

Finnish_boy
Finnish_boy Dec. 26 at 11:14 PM
$HROW ATH in February!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 11:02 PM
$HROW This MVI data shows that Q4 will be enough ok. I think markets start to price in huge growth that happens next year. Markets dont care much will FY25 be 265m, 270m or 275-280m. Q4 report can cause some quick reaction either way but SP is heading to $100 next year !!!! My bet is now that SP wont drop under $40 ever !!!!
1 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 8:54 PM
$HROW HIMS $34, HROW $50.. i was right this time. i told earlier that hrow this year > hims when there was big gap. 95% of times i am wrong. i think hrow wont drop anymore under $40 levels. i think harrow can run to ATH before Q4 report. if report disappoints, hrow can drop under $50, but not to $40. If report awesome, then path to $80 in H1.
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 8:32 PM
$HROW Byqlovi launch in 3 weeks
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 8:20 PM
$HROW Shorts are covering.
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:49 PM
$HROW Shorts thinking should they cover today or tomorrow. I can tell that markets not open tomorrow so have to cover on Monday then !!!!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:47 PM
$HROW I lower odds for under $40 levels from 25% to 10%.
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:32 PM
$HROW ATH in H1 next year. VEVYE momentum will be massive !! coverage, more reps, new markets !! boom!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:31 PM
$HROW VEVYE rocketing started !!
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 6:21 PM
$HROW Very bullish https://x.com/Michigan_Value/status/2004612869246386630?s=20
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 5:32 PM
$HROW My all positions. My biggest positions are HROW, PYPD, and GOSS. Both PYPD and GOSS are Jan-Feb setups, i try to make tons of profits and roll all the profits into HROW. IREN and CIFR will double also next year. HITI is incredible undervalued but not sure when markets give higher multiple.
0 · Reply
flash9875
flash9875 Dec. 26 at 4:30 PM
$HROW long may you run…
0 · Reply
flash9875
flash9875 Dec. 26 at 4:24 PM
$HROW look for Prancer…just arrived…
0 · Reply
flash9875
flash9875 Dec. 26 at 4:13 PM
$HROW all of Santa’s helpers are waking up…
0 · Reply
flash9875
flash9875 Dec. 26 at 3:50 PM
$HROW look for the rudolph reversal
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 3:50 PM
$HROW Feels like shorts are covering. They realized also that nobody cares about FY25 total revenue.
0 · Reply
Finnish_boy
Finnish_boy Dec. 26 at 10:06 AM
$HROW My odds for under $40 levels dropped from 50% to 25%. Hold maximum position already in H1 next year. SP will explode from H1 to H2. DONT MISS THIS !!
0 · Reply
Tennis_4567
Tennis_4567 Dec. 25 at 10:59 AM
$HROW short interest actually went down.
2 · Reply
Fullback
Fullback Dec. 24 at 4:31 PM
$HROW Merry Christmas and Happy Holidays to all my StockTwits friends! Looking forward to a Great 2026!
0 · Reply
Finnish_boy
Finnish_boy Dec. 24 at 3:47 PM
$HROW $50
1 · Reply
Finnish_boy
Finnish_boy Dec. 23 at 4:07 PM
$HROW Vevye coverage kicking in 2 weeks🤑
2 · Reply
Finnish_boy
Finnish_boy Dec. 23 at 4:07 PM
$HROW Too many people ignore this fact ⬇️
1 · Reply